Another report suggested that higher GDF11/myostatin circulating levels were associated with a lower risk of cardiovascular events and death [5], and a separate study demonstrated that GDF11 did not decline with age and was associated with a higher risk of cardiovascular diseases [36]. Here, GDF11 is linked to cardiovascular disorder.